Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 105,622 shares, an increase of 92.3% from the January 15th total of 54,935 shares. Based on an average trading volume of 975 shares, the days-to-cover ratio is currently 108.3 days. Based on an average trading volume of 975 shares, the days-to-cover ratio is currently 108.3 days.
Avacta Group Stock Performance
Shares of OTCMKTS:AVCTF opened at $0.80 on Friday. The company’s fifty day moving average is $0.85 and its 200-day moving average is $0.87. Avacta Group has a 52 week low of $0.40 and a 52 week high of $1.11.
About Avacta Group
Avacta Group plc is a UK-based biotechnology company specializing in the discovery, development and commercialization of Affimer® biotherapeutics and diagnostic reagents. The company’s proprietary Affimer platform uses small, engineered protein scaffolds that can be tailored to bind specifically to target molecules, offering an alternative to traditional antibodies. Avacta operates two core divisions: Avacta Therapeutics, which focuses on novel treatments in oncology and immune-related diseases, and Avacta Analytical, which develops reagents and point-of-care diagnostic tests.
In its diagnostics business, Avacta has applied the Affimer technology to lateral flow assays, most notably for rapid detection of viral pathogens such as SARS-CoV-2.
Featured Stories
- Five stocks we like better than Avacta Group
- ALERT: Drop these 5 stocks before January 2026!
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Buy This Stock Now
- The Next Commodity Crunch (bigger than oil?)
- Silicon Valley insiders hint at 12-month AI warning
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
